Collegium Pharmaceutical (COLL) EBIT Growth (5y) (2019 - 2026)
Collegium Pharmaceutical (COLL) EBIT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Collegium Pharmaceutical | 892.02 Mn | 742.71 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.77% |
| Mar 31, 2026 | 7.83% |
| Dec 31, 2025 | 32.29% |
| Sep 30, 2025 | 25.90% |
| Jun 30, 2025 | 16.23% |
| Mar 31, 2025 | 33.78% |
| Dec 31, 2024 | 78.38% |
| Sep 30, 2024 | 49.49% |
| Jun 30, 2024 | 62.92% |
| Mar 31, 2024 | 47.37% |
| Dec 31, 2023 | 41.17% |
| Sep 30, 2023 | 43.21% |
| Jun 30, 2023 | 47.09% |
| Mar 31, 2023 | 31.05% |
| Dec 31, 2022 | 21.69% |
| Sep 30, 2022 | 28.65% |
| Jun 30, 2022 | 20.33% |
| Mar 31, 2022 | 15.45% |
| Dec 31, 2021 | -4.35% |
| Sep 30, 2021 | 20.45% |